Creekmur Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-122
Closed -$5.64K – 846
2025
Q2
$5.64K Buy
122
+2
+2% +$98 ﹤0.01% 563
2025
Q1
$7.34K Buy
120
+1
+0.8% +$58 ﹤0.01% 522
2024
Q4
$6.74K Buy
119
+1
+0.8% +$56 ﹤0.01% 463
2024
Q3
$6.1K Buy
118
+2
+2% +$94 ﹤0.01% 511
2024
Q2
$4.83K Sell
116
-32
-22% -$1.43K ﹤0.01% 585
2024
Q1
$8.02K Buy
148
+35
+31% +$1.78K ﹤0.01% 506
2023
Q4
$5.82K Buy
+113
New +$5.93K ﹤0.01% 578

Other funds holding BMY

Creekmur Asset Management's BMY Position: Q3 2025 in Review

Creekmur Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 122 shares — an estimated $5.64K sold.

Creekmur Asset Management first reported a position in BMY in Q4 2023 and held it in 7 quarters. The position peaked at $8.02K in Q1 2024. 2,276 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Creekmur Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Creekmur Asset Management sold 122 Bristol-Myers Squibb shares in Q3 2025, an estimated $5.64K.
  • Creekmur Asset Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 7 quarters.
  • Creekmur Asset Management's Bristol-Myers Squibb position peaked at $8.02K in Q1 2024.
  • 2,276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.